582 related articles for article (PubMed ID: 25281470)
41. Transient adult T-cell leukemia/lymphoma picture during varicella infection in an HTLV-1 carrier.
D'Incan M; Combemale P; Verrier B; Garin D; Audoly G; Brunot J; Desgranges C; Fléchaire A
Leukemia; 1994 Apr; 8(4):682-7. PubMed ID: 8152266
[TBL] [Abstract][Full Text] [Related]
42. Clinical significance of monocytosis and human monocytic colony-stimulating factor in patients with adult T-cell leukaemia/lymphoma.
Tokioka T; Shimamoto Y; Motoyoshi K; Yamaguchi M
Haematologia (Budap); 1994; 26(1):1-9. PubMed ID: 7959369
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of human T-cell leukemia virus type 1 (HTLV-I) in adult T-cell leukemia (ATL) in non-ATL-endemic Hokkaido of Japan.
Iwanaga M; Takada K; Fujiwara S; Oikawa O; Sugiura M; Imai S; Osato T; Mikuni C; Maekawa I; Miyazaki T
In Vivo; 1994; 8(6):1007-10. PubMed ID: 7772727
[TBL] [Abstract][Full Text] [Related]
44. Renal transplantation in patients with human T-cell lymphotropic virus type 1.
Shirai H; Suzuki M; Tomita Y; Iwadoh K; Kai K; Sannomiya A; Koyama I; Nakajima I; Fuchinoue S
Transplant Proc; 2012 Jan; 44(1):83-6. PubMed ID: 22310586
[TBL] [Abstract][Full Text] [Related]
45. [Adult T cell leukemia/lymphoma (ATL)].
Tanosaki R
Nihon Rinsho; 2003 Sep; 61(9):1592-5. PubMed ID: 14515729
[TBL] [Abstract][Full Text] [Related]
46. Immunological risks of adult T-cell leukemia at primary HTLV-I infection.
Kannagi M; Ohashi T; Harashima N; Hanabuchi S; Hasegawa A
Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062
[TBL] [Abstract][Full Text] [Related]
47. Clinical trials for human T-cell lymphotropic virus type I-associated peripheral T-cell lymphoma in Japan.
Tobinai K
Semin Hematol; 2010 Apr; 47 Suppl 1():S5-7. PubMed ID: 20359583
[TBL] [Abstract][Full Text] [Related]
48. Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home.
Dittus C; Sloan JM
Hematol Oncol Clin North Am; 2017 Apr; 31(2):255-272. PubMed ID: 28340877
[TBL] [Abstract][Full Text] [Related]
49. Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.
Ishitsuka K; Tsukasaki K; Tamura K
Drugs Today (Barc); 2011 Aug; 47(8):615-23. PubMed ID: 21850284
[TBL] [Abstract][Full Text] [Related]
50. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.
Malpica L; Pimentel A; Reis IM; Gotuzzo E; Lekakis L; Komanduri K; Harrington T; Barber GN; Ramos JC
Blood Adv; 2018 Mar; 2(6):607-620. PubMed ID: 29545256
[TBL] [Abstract][Full Text] [Related]
51. Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
Katsuya H; Ishitsuka K
J Clin Exp Hematop; 2017 Dec; 57(3):87-97. PubMed ID: 28592744
[TBL] [Abstract][Full Text] [Related]
52. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
Bazarbachi A; Hermine O
Virus Res; 2001 Oct; 78(1-2):79-92. PubMed ID: 11520582
[TBL] [Abstract][Full Text] [Related]
53. Adult T-cell leukemia/lymphoma.
Qayyum S; Choi JK
Arch Pathol Lab Med; 2014 Feb; 138(2):282-6. PubMed ID: 24476526
[TBL] [Abstract][Full Text] [Related]
54. Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals.
Hishizawa M; Imada K; Kitawaki T; Ueda M; Kadowaki N; Uchiyama T
Br J Haematol; 2004 Jun; 125(5):568-75. PubMed ID: 15147371
[TBL] [Abstract][Full Text] [Related]
55. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy.
Taylor GP; Matsuoka M
Oncogene; 2005 Sep; 24(39):6047-57. PubMed ID: 16155611
[TBL] [Abstract][Full Text] [Related]
56. Detection of preleukemic state of adult T-cell leukemia (pre-ATL) in HTLV-1 carriers.
Ikeda S; Momita S; Amagasaki T; Tsukasaki K; Yamada Y; Kusumoto Y; Ito M; Kanda N; Tomonaga M; Soda H
Cancer Detect Prev; 1990; 14(4):431-5. PubMed ID: 2224908
[TBL] [Abstract][Full Text] [Related]
57. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma.
Katsuya H; Yamanaka T; Ishitsuka K; Utsunomiya A; Sasaki H; Hanada S; Eto T; Moriuchi Y; Saburi Y; Miyahara M; Sueoka E; Uike N; Yoshida S; Yamashita K; Tsukasaki K; Suzushima H; Ohno Y; Matsuoka H; Jo T; Suzumiya J; Tamura K
J Clin Oncol; 2012 May; 30(14):1635-40. PubMed ID: 22473153
[TBL] [Abstract][Full Text] [Related]
58. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M
J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215
[TBL] [Abstract][Full Text] [Related]
59. Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).
Ceesay MM; Matutes E; Taylor GP; Fields P; Cavenagh J; Simpson S; Ho A; Devereux S; Mufti GJ; Pagliuca A
Leuk Res; 2012 Jul; 36(7):857-61. PubMed ID: 22209076
[TBL] [Abstract][Full Text] [Related]
60. Skin lesions and cytological features in HTLV-1 associated adult T-cell leukaemia/lymphoma.
Marquet J; Piris-Villaespesa M; Rodriguez E; López S; Villarrubia J; García-Vela JA
Br J Haematol; 2017 May; 177(4):507. PubMed ID: 28295186
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
